{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:31:28Z","timestamp":1792762288170,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"Importance<\/jats:title>Antibiotics are commonly prescribed in primary care, increasing the risk of antimicrobial resistance in the population.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate the effect of quarterly audit and feedback on antibiotic prescribing among primary care physicians in Switzerland with medium to high antibiotic prescription rates.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This pragmatic randomized clinical trial was conducted from January 1, 2018, to December 31, 2019, among 3426 registered primary care physicians and pediatricians in single or small practices in Switzerland who were among the top 75% prescribers of antibiotics. Intention-to-treat analysis was performed using analysis of covariance models and conducted from September 1, 2021, to January 31, 2022.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Primary care physicians were randomized in a 1:1 fashion to undergo quarterly antibiotic prescribing audit and feedback with peer benchmarking vs no intervention for 2 years, with 2017 used as the baseline year. Anonymized patient-level claims data from 3 health insurers serving roughly 50% of insurees in Switzerland were used for audit and feedback. The intervention group also received evidence-based guidelines for respiratory tract and urinary tract infection management and community antibiotic resistance information. Physicians in the intervention group were blinded regarding the nature of the trial, and physicians in the control group were not informed of the trial.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The claims data used for audit and feedback were analyzed to assess outcomes. Primary outcome was the antibiotic prescribing rate per 100 consultations during the second year of the intervention. Secondary end points included overall antibiotic use in the first year and over 2 years, use of quinolones and oral cephalosporins, all-cause hospitalizations, and antibiotic use in 3 age groups.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 3426 physicians were randomized to the intervention (n\u2009=\u20091713) and control groups (n\u2009=\u20091713) serving 629\u202f825 and 622\u202f344 patients, respectively, with a total of 4\u202f790\u202f525 consultations in the baseline year of 2017. In the entire cohort, a 4.2% (95% CI, 3.9%-4.6%) relative increase in the antibiotic prescribing rate was noted during the second year of the intervention compared with 2017. In the intervention group, the median annual antibiotic prescribing rate per 100 consultations was 8.2 (IQR, 6.1-11.4) in the second year of the intervention and was 8.4 (IQR, 6.0-11.8) in the control group. Relative to the overall increase, a \u20130.1% (95% CI, \u20131.2% to 1.0%) lower antibiotic prescribing rate per 100 consultations was found in the intervention group compared with the control group. No relevant reductions in specific antibiotic prescribing rates were noted between groups except for quinolones in the second year of the intervention (\u20130.9% [95% CI, \u20131.5% to \u20130.4%]).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This randomized clinical trial found that quarterly personalized antibiotic prescribing audit and feedback with peer benchmarking did not reduce antibiotic prescribing among primary care physicians in Switzerland with medium to high antibiotic prescription rates.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03379194<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2022.6529","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T16:05:57Z","timestamp":1675699557000},"page":"213","source":"Crossref","is-referenced-by-count":41,"title":["Effect of Antibiotic Prescription Audit and Feedback on Antibiotic Prescribing in Primary Care"],"prefix":"10.1001","volume":"183","author":[{"given":"Soheila","family":"Aghlmandi","sequence":"first","affiliation":[{"name":"Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian S.","family":"Halbeisen","sequence":"additional","affiliation":[{"name":"Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Saccilotto","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godet","sequence":"additional","affiliation":[{"name":"Sanitas Insurance Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri","family":"Signorell","sequence":"additional","affiliation":[{"name":"Helsana Insurance Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sigrist","sequence":"additional","affiliation":[{"name":"CSS Insurance Lucerne, Lucerne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Glinz","sequence":"additional","affiliation":[{"name":"Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Moffa","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Computer Science, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zeller","sequence":"additional","affiliation":[{"name":"Centre for Primary Health Care, University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas F.","family":"Widmer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Hygiene, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronenberg","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bielicki","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Paediatric Pharmacology, University Children\u2019s Hospital Basel and University of Basel, Basel, Switzerland"},{"name":"Centre for Neonatal and Paediatric Infection, St George\u2019s University London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner C.","family":"Bucher","sequence":"additional","affiliation":[{"name":"Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"ioi220083r1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement rates.","volume":"17","author":"Akkerman","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"ioi220083r2","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1093\/jac\/dku291","article-title":"Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations.","volume":"69","author":"Hawker","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ioi220083r3","doi-asserted-by":"publisher","first-page":"i43","DOI":"10.1093\/jac\/dkm156","article-title":"Antibacterial prescribing in primary care.","volume":"60","author":"Petersen","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"ioi220083r4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001726.pub2","article-title":"Antibiotics for acute bronchitis.","author":"Smucny","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"ioi220083r5","doi-asserted-by":"publisher","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"issue":"9459","key":"ioi220083r6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"ioi220083r7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/jac\/dkm141","article-title":"Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.","volume":"60","author":"Hillier","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ioi220083r8","doi-asserted-by":"publisher","first-page":"d8173","DOI":"10.1136\/bmj.d8173","article-title":"Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial.","volume":"344","author":"Butler","year":"2012","journal-title":"BMJ"},{"key":"ioi220083r9","doi-asserted-by":"publisher","first-page":"f4403","DOI":"10.1136\/bmj.f4403","article-title":"Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study).","volume":"347","author":"Gjelstad","year":"2013","journal-title":"BMJ"},{"issue":"10029","key":"ioi220083r10","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0140-6736(16)00215-4","article-title":"Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial.","volume":"387","author":"Hallsworth","year":"2016","journal-title":"Lancet"},{"key":"ioi220083r11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamainternmed.2016.8040","article-title":"Personalized prescription feedback using routinely collected data to reduce antibtiotic use in primary care: a randomized clinical trial.","volume":"177","author":"Hemkens","year":"2017","journal-title":"JAMA Intern Med"},{"key":"ioi220083r12","doi-asserted-by":"publisher","first-page":"l236","DOI":"10.1136\/bmj.l236","article-title":"Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.","volume":"364","author":"Gulliford","year":"2019","journal-title":"BMJ"},{"issue":"7182","key":"ioi220083r13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/bmj.318.7182.507","article-title":"Randomised controlled trial of effect of feedback on general practitioners\u2019 prescribing in Australia.","volume":"318","author":"O\u2019Connell","year":"1999","journal-title":"BMJ"},{"issue":"9","key":"ioi220083r14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/jamainternmed.2021.2790","article-title":"Effect of antibiotic-prescribing feedback to high-volume primary care physicians on number of antibiotic prescriptions: a randomized clinical trial.","volume":"181","author":"Schwartz","year":"2021","journal-title":"JAMA Intern Med"},{"key":"ioi220083r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100712","article-title":"Antibiotic prescription monitoring and feedback in primary care in Switzerland: Design and rationale of a nationwide pragmatic randomized controlled trial.","volume":"21","author":"Glinz","year":"2021","journal-title":"Contemp Clin Trials Commun"},{"issue":"11","key":"ioi220083r16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"16","key":"ioi220083r17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2019.3087","article-title":"Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement.","volume":"321","author":"Juszczak","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"ioi220083r18","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.","volume":"308","author":"Piaggio","year":"2012","journal-title":"JAMA"},{"key":"ioi220083r20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12879-016-1739-0","article-title":"Personalized prescription feedback to reduce antibiotic overuse in primary care: rationale and design of a nationwide pragmatic randomized trial.","volume":"16","author":"Hemkens","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ioi220083r22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/biom.v75.4","article-title":"Analysis of covariance in randomized trials: more precision and valid confidence intervals, without model assumptions.","volume":"75","author":"Wang","year":"2019","journal-title":"Biometrics"},{"issue":"7","key":"ioi220083r23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/0272989X19866699","article-title":"The effect of expert feedback on antibiotic prescribing in pediatrics: experimental evidence.","volume":"39","author":"Eilermann","year":"2019","journal-title":"Med Decis Making"},{"issue":"1","key":"ioi220083r24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jac\/dkv328","article-title":"Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: the ARTI4 randomized trial.","volume":"71","author":"van der Velden","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ioi220083r25","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jama.2016.0275","article-title":"Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial.","volume":"315","author":"Meeker","year":"2016","journal-title":"JAMA"},{"issue":"14","key":"ioi220083r26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1001\/jama.2017.11152","article-title":"Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions.","volume":"318","author":"Linder","year":"2017","journal-title":"JAMA"},{"issue":"1544","key":"ioi220083r27","first-page":"13","article-title":"Using a randomised controlled trial to test the effectiveness of social norms feedback to reduce antibiotic prescribing without increasing inequities.","volume":"134","author":"Chappell","year":"2021","journal-title":"N Z Med J"},{"key":"ioi220083r28","doi-asserted-by":"publisher","first-page":"vi47","DOI":"10.1093\/jac\/dkr457","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ioi220083r31","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1093\/jac\/dkx278","article-title":"Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey.","volume":"72","author":"Glinz","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"10325","key":"ioi220083r32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ioi220083r33","doi-asserted-by":"publisher","first-page":"m3256","DOI":"10.1136\/bmj.m3256","article-title":"Details matter: predicting when nudging clinicians will succeed or fail.","volume":"370","author":"Fox","year":"2020","journal-title":"BMJ"},{"key":"ioi220083r19","unstructured":"R Core Team. R: a language and environment for statistical computing. 2017. R Foundation for Statistical Computing. Accessed May 10, 2022. https:\/\/www.R-project.org\/"},{"key":"ioi220083r21","unstructured":"Institut f\u00fcr Infektionskrankheiten. Swiss Centre for Antibiotic Resistance. Accessed May 10, 2022. http:\/\/www.anresis.ch"},{"key":"ioi220083r29","unstructured":"European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union. ESAC-Net surveillance data. November 2016. Accessed May 10, 2022. http:\/\/ecdc.europa.eu\/en\/eaad\/antibiotics-get-informed\/antibiotics-resistance-consumption\/Pages\/data-reports.aspx"},{"key":"ioi220083r30","unstructured":"Federal Office of Public Health; Federal Food Safety and Veterinary Office. Swiss antibiotic resistance report 2016. FOPH publication number: 2016-OEG-30. Accessed May 10, 2022. https:\/\/www.bag.admin.ch\/bag\/en\/home\/das-bag\/publikationen\/broschueren\/publikationen-uebertragbare-krankheiten\/publikation-swiss-antibiotic-resistance-report-2016.html"},{"key":"ioi220083r34","unstructured":"Eidgen\u00f6ssisches Departement des Innern Bundesamt f\u00fcr Gesundheitswesen. Informationsmagazin f\u00fcr medizinische Fachpersonen und Medienschaffende: BAG-Bulletin. February 10, 2020. Accessed May 10, 2022. https:\/\/www.bag.admin.ch\/dam\/bag\/de\/dokumente\/cc\/Kampagnen\/Bulletin\/2020\/bu-7-20.pdf.download.pdf\/BU_7_20_DE.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2800887\/jamainternal_aghlmandi_2023_oi_220083_1677616708.87976.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T16:02:54Z","timestamp":1678118574000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2800887"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2022.6529","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}